# Bedside Genetic or Pharmacodynamic Testing to Prevent Periprocedural Myonecrosis During PCI (ONSIDE TEST)

Study · id `cardio:ct-nct01930773` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01930773](<https://clinicaltrials.gov/study/NCT01930773>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT01930773

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 150 participants.

## Technical summary

Registry record NCT01930773. Randomized; no masking; primary purpose prevention. Start 2013-03 (registry gives no type); primary completion 2019-03 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Phase 3
- Enrolled: 150 participants (planned count; ClinicalTrials.gov record NCT01930773, source copy `cardio:ctgov-nct01930773-2018-12-24`, retrieved 2026-10-31)
- Start date: 2013-03 (registry gives no type) (ClinicalTrials.gov record NCT01930773, source copy `cardio:ctgov-nct01930773-2018-12-24`, retrieved 2026-10-31)
- Primary completion: 2019-03 (anticipated) (ClinicalTrials.gov record NCT01930773, source copy `cardio:ctgov-nct01930773-2018-12-24`, retrieved 2026-10-31)
- Completion: 2019-09 (anticipated) (ClinicalTrials.gov record NCT01930773, source copy `cardio:ctgov-nct01930773-2018-12-24`, retrieved 2026-10-31)
- Countries: Hungary; Poland (ClinicalTrials.gov record NCT01930773, source copy `cardio:ctgov-nct01930773-2018-12-24`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01930773-2018-12-24`, retrieved 2026-10-31)

## The registry's words

- Brief title: Bedside Genetic or Pharmacodynamic Testing to Prevent Periprocedural Myonecrosis During PCI (ONSIDE TEST)
- Acronym: ONSIDE TEST
- Condition: Stable Angina
- Intervention (Device): Genotyping
- Intervention (Device): Phenotyping
- Lead sponsor: Medical University of Warsaw
- Lead sponsor class: OTHER
- Collaborator: Polish Cardiac Society
- Collaborator class: OTHER
- Collaborator: University of Pecs
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Stable angina (`cardio:stable-angina`)
- Registry lists this organization as the lead sponsor: Medical University of Warsaw (`cardio:org-medical-university-of-warsaw`)

## Provenance

Content hash: a5a7ea82435693ed9066452577a8feb0b36ea76eb62af73e9ff4eb089459f7ec
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
